Avalo Therapeutics Inc (NAS:AVTX)
$ 9.55 -0.44 (-4.4%) Market Cap: 99.93 Mil Enterprise Value: 18.62 Mil PE Ratio: 0 PB Ratio: 4.39 GF Score: 47/100

Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript

Oct 19, 2021 / 12:00PM GMT
Release Date Price: $6451.2 (+1.36%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot